What’s the deal with Alzheimer’s disease and amyloid?

MrFred

Wise, Aged Ars Veteran
172
Subscriptor
Spoken as someone who actually started on the path of this as a research topic years ago, before life got in the way, luckily I suppose: I hope the frauds [...skips stuff that would get me in trouble...] and their engines blow out at 100 001 miles on their new cars, and their cell phones at 366 days for the rest of their lives.

More constructively, validating others' results and testing their conclusions is real science. Not as glamorous but obviously undervalued, as demonstrated here.
 
Upvote
87 (87 / 0)
Felt like exercising a muscle!
I was coming to the comments to compliment you on an excellent article outside your automotive beat.

My only nit would be to say that we have developed a clinically-demonstrated vaccine that actually has a measurable improvement in Alzheimer's prevention and symptom progression. Beth Mole wrote about it in February. The entire Alzheimer's research community should have massive egg on their face as far as the shingles vaccines are concerned. The accidental protection afforded by them has far more clinical data supporting its use to mitigate effects of Alzheimer's than anything targeting amyloids. That particular footnote should have probably made it into the article somewhere.
 
Upvote
247 (248 / -1)
The amyloid plaque hypothesis is arguably the canonically cautionary tale that correlation is not necessarily causation.

There have been those (like Derek Lowe on his 'In the Pipeline' blog) who've been drawing attention to all the drug failures and what that might imply for a long time.

Don't even mention how much money has been spent on this to date.
 
Upvote
113 (113 / 0)

TheGnome

Ars Praefectus
4,219
Subscriptor
I find it interesting and probably more than co-incidental that the vast majority of cases of scientific fraud and misconduct occur in clinical/pharmaceutical research fields. When there's so much money to be made, there's an almost irresistible incentive to cut corners if not commit outright fraud.

It's far less common to find incidents of fraud among researchers working on fundamental, curiosity-driven science. Maybe if we directed more resources to publicly funded academic research this would be less of a problem?
 
Upvote
60 (61 / -1)

nooneofconsequence

Smack-Fu Master, in training
76
Subscriptor
Dr. Gitlin - your thoughts on white matter disease vs Alzheimers would be cool to read. Dad had Alzheimers and I have advanced white matter disease. Balance, route finding and task switching already taking a hit. It's an odd feeling when something else doesn't work right, my brain notices and is like yeah, not today.

Edit to add: and migraines. My neuro doc mentioned possible link in my case to migraines. FWIW, I took 5 doses of a CGRP antagonist and was migraine free for quite a few years.
 
Upvote
51 (51 / 0)
Post content hidden for low score. Show…
Great to see a mainstream article recognise the staggering scale of groupthink over the amyloid plaque hypothesis.

The utter failure of tackling amyloid plaques in Alzheimer's disease seems to be having real blowback in terms of little-to-no willingness from pharma to invest in related research, which is a shame as amyloids don’t just form disordered plaques/tangles, they also form more ordered structures that can interact with other factors cited in the article as part of an ensemble of factors driving neurodegenerative conditions, and whose existence has been known for for decades - all ignored in favour of the flawed plaque hypothesis.
 
Upvote
36 (36 / 0)
From what I've seen of the research over vitamin b1 (thiamine) and Alzheimer's, dietary changes offer only minimal benefit if any. There is a therapeutic trial going on where they use a thiamine precursor to boost brain levels of B1 very substantially. Pre-trial research has shown a reduction of cognitive impaiment progression in early-stage Alzheimer's patients, but data is obviously still pending from the full trial. So assuming that research bears fruit (and there have certainly been decades of hopes for treatments that didn't pan out) then it is an interesting and potential useful treatment.

Eating better is a good idea generally, but the idea that that improving b1 through diet will significantly prevent or slow Alzheimer's is simply bullshit.
 
Upvote
50 (51 / -1)

randomuser42

Ars Tribunus Militum
1,764
Subscriptor++
Finally, seeing is believing, an 84 year old woman with dementia unable to read.
Does she have dementia or does she have cognitive impairment from a condition like beriberi which is usually quickly and effectively reversed with lots of vitamin B1?
 
Upvote
55 (55 / 0)

Freedom-MD

Smack-Fu Master, in training
22
"In other words, low levels of Vitamin B1 = VERY BAD."
Yes, deficiency of Vitamin B1 can cause cognitive impairment, just as deficiencies of Vitamin B6 and Vitamin B12 can. But that's not Alzheimer's dementia even if it can coexist with Alzheimer's dementia.
 
Upvote
86 (86 / 0)

eaglefalconn

Seniorius Lurkius
9
Subscriptor++
Great article. I was working on my PhD in the early 2010s in Chemistry and I could see how distorting the beta-amyloid hypothesis was. Obviously I had no way to know it was built on a pyramid of lies, but seemingly everyone who needed an excuse to pursue something would find a way to say it helped learn more about beta-amyloids. Ultra-fast spectroscopy, quantum and molecular dynamics simulations, biochemical pathway exploration....so much money wasted studying a seemingly pointless target.

I have enough trust in the scientific enterprise to know that important things were still learned from those studies. And perhaps the improvement in techniques, the students trained and the knowledge generated will still have some sort of societal return in the future that's just hard to track.

But in an era when funding for good science was hard to come by and when people were just starting to realize that the pathway to a career as an academic was dead, I can't help but think about all the people with great ideas who weren't susceptible to the groupthink. Which one of those ideas was actually brilliant? With the decline of US science funding, we may never know...until the Chinese do it.
 
Upvote
55 (55 / 0)

Ecnhoffer

Wise, Aged Ars Veteran
178
Subscriptor
Cognitive decline largely starts with a consistent, protracted (talking YEARS here) of a deficiency of Vitamin B1. When you're 10 years of age, a few milligrams of Vitamin B1 will do, but the need for it grows EXPONENTIALLY as you age. When I say, EXPONENTIALLY, I don't mean the layman's use of the word, i.e., "a lot" I mean powers of 10.

From the National Institutes of Health:

https://pubmed.ncbi.nlm.nih.gov/29490669/

"FDG SUVRs in frontal, temporal, and parietal cortices of patients with AD (Alzheimer's Disease) were closely correlated with the levels of blood thiamine (Vitamin B1) diphosphate (TDP) and cognitive abilities"

Another paper:

https://pmc.ncbi.nlm.nih.gov/articles/PMC4846521/

In other words, low levels of Vitamin B1 = VERY BAD.

The other bad news is many of you lead a life style that promotes the loss of Vitamin B1. I'm talking about high levels of carbohydrate consumption. And sorry vegan/vegetarians, but foods that turn into sugar readily promote the loss of Vitamin B1. And no, you can't go measure it, the only B vitamin that is capable of being stored in your body Vitamin B12, hence the reason it's the only B vitamin spoken about in blood work. All the other B vitamins are a situation of "use it or lose it." And unfortunately as stress in life increases, the more easily you lose Vitamin B1. And if you're diabetic, woe to you, diabetics lose Vitamin B1 at a rate 20x that of a non-diabetics, hence their significant risk of dementia. Dementia is the collapse of the myelin tissue in your brain. Three quarters of your brain is myelin tissue and it is made DIRECTLY from Vitamin B1.

Finally, seeing is believing, an 84 year old woman with dementia unable to read... she is given extremely high amounts of Vitamin B1 including a fat soluble form of Vitamin B1 called BENFOTIAMINE (developed by the Japanese) since in fat soluble form it crosses the blood/brain barrier and has a much more pronounced effect. Watch what happens...


View: https://www.youtube.com/shorts/ukalfGQ0R04


As the antagonist in the movie "Time Cop" says tells his younger self, "Do us both a favor and lay off the effing candy bars."

You may want to include this one:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6459027/
of course there has been and continues to be a market for supplements over the life of individuals.
 
Upvote
13 (13 / 0)

Oldmanalex

Ars Legatus Legionis
11,808
Subscriptor++
At various times I have been adjacent to Alzheimer's research, while avoiding being actively involved. A very difficult field, but it was evident from the beginning that amyloid plaques suffered from the cart and horse conundrum, and maybe clearing amyloid would be beneficial, but equally well maybe not. Was it the cause (seemed improbable) or an effect, and if it was an effect was it in itself causing further damage, which was quite plausible. So the experiments were worth doing, but should not have become the whole ball of wax. One of the things which puzzled me was the absolute lack of interest in our AD colleagues over the role of the intramolecular large fragment of the APP. Does it behave differently after the amyloid cleavage has occurred? Does it tie into various cellular signaling pathways, like most transmembrane proteins with a prominent intracellular domain? There are cell surface receptors which are activated by proteolysis. Is APP one of them? Does the APP cleavage, or something else tie in with the obviously damaging, like punch holes through cell membranes, phosphorylation of Tau, and formation of paired helical filaments? There just seemed to be a lack of curiosity about other explanations.
 
Upvote
50 (50 / 0)

Martin Blank

Ars Tribunus Militum
2,608
Subscriptor++
From the National Institutes of Health:
That line right there undermines your entire post because it displays a lack of understanding of the source of the papers. The papers are not from the NIH. Your links are to the National Library of Medicine, which is a database of papers from many journals, including some of questionable value. Your first link is from Alzheimer's Research & Therapy, while the second is from the Annals of the New York Academy of Sciences.

In addition, just reading the abstracts, both papers note correlation and not causation. Both are interesting, but if B1 were the solution, it would have been pinned down decades ago.
 
Upvote
77 (77 / 0)
My guess, and it is just a guess as I am just a lowly retired pharmacist, is that the amyloid is a result of the disease causing pathology, not the cause.
I think this is a quite popular position. Not mentioned in the article, but as far as anybody knows beta-amyloid is part of the brain's immune response! So if the brain was (or thought it was) fighting off a viral infection you'd expect to see it overproduced. I learned about that... a decade ago? Something like that. To me the weirdest part of the whole 'beta amyloid' controversy is how slowly it's moved. People have doubted it for decades but the research pipeline just ground on.

I find it interesting and probably more than co-incidental that the vast majority of cases of scientific fraud and misconduct occur in clinical/pharmaceutical research fields. When there's so much money to be made, there's an almost irresistible incentive to cut corners if not commit outright fraud.

It's far less common to find incidents of fraud among researchers working on fundamental, curiosity-driven science. Maybe if we directed more resources to publicly funded academic research this would be less of a problem?
I quite strongly disagree here. It may be correct(ish) to say that the majority of discovered or reported or fraud anybody seems to care about is in clinical fields, but very very few other fields have billions of dollars invested on the back of that fraudulent research, and investors want to know why their billions of dollars turned into smoke and drifted away.

We've moved from a replication crisis into a shit-tsunami in the scientific literature. I believe in science as an endeavor and it still slowly triangulates towards as close as we can come to truth... but damn it's rough at the moment.

I don't think public funding actually helps on this. If you're working a niche field nobody else will ever care about, and one more paper this year means you're secure in your position... why not exaggerate the importance of this obscure protein? Frankly as person who chose industry over science, I feel like industry has stronger incentive to be honest. They don't share mind you, but they're usually honest internally because like I said about pharma, they care about wasting money on ideas that don't pan out.

I guess that brings us back around to pharma being evil, because there is no way the pharma researchers looked at their data and went, "Yup, that's a theory proved out right there." Somewhere internally there's a pile of burnt documents that say, "This is crap and we should bin it."
 
Last edited:
Upvote
36 (38 / -2)

SimonW

Ars Tribunus Militum
1,621
Subscriptor
“It became gradually an infallible belief system. So everybody felt obligated to pay homage to the idea without questioning. And that’s not very healthy for science when scientists… accept an idea as infallible. That’s when you run into problems.”
I think this is one of the major problems with how we do scientific research. I've been doing research for 30 years (eek) and see, time and time again, that we cleave to ideas that have entered scientific cannon, yet have done so based upon pretty scant data that was never rigorously replicated. Because rigorous replication is hardly sexy science nor particularly easy to get funding for. I confess I have been guilty of this sin, time and time again. But the high points of my career have been when I've, by luck or persistence, pulled the curtain back to find not the paradigmatic unquestionable wizard, but just a little man pulling some levers
 

Attachments

  • Wizard6.jpg
    Wizard6.jpg
    30.8 KB · Views: 30
Upvote
12 (12 / 0)

Melaskia

Smack-Fu Master, in training
64
Subscriptor++
I am not surprised by this article. In fact during my grad school in late 90s, I was taught that while beta amyloid was more likely to be a consequence of the disease than the cause and that targeting may or may not have an impact. The idea of just targeting it was considered stupid by my teacher back then
 
Upvote
21 (21 / 0)
I am not surprised by this article. In fact during my grad school in late 90s, I was taught that while beta amyloid was more likely to be a consequence of the disease than the cause and that targeting may or may not have an impact. The idea of just targeting it was considered stupid by my teacher back then
There are studies showing that folks who take the Shingles vaccines have a reduced chance of developing dementia.
 
Upvote
18 (18 / 0)

SixDegrees

Ars Legatus Legionis
48,454
Subscriptor
There are studies showing that folks who take the Shingles vaccines have a reduced chance of developing dementia.
It's looking like this may be true for other vaccines as well, and that maybe there's a link with reduced inflammation in general leading to lower dementia rates.
 
Upvote
23 (23 / 0)
At various times I have been adjacent to Alzheimer's research, while avoiding being actively involved. A very difficult field, but it was evident from the beginning that amyloid plaques suffered from the cart and horse conundrum, and maybe clearing amyloid would be beneficial, but equally well maybe not. Was it the cause (seemed improbable) or an effect, and if it was an effect was it in itself causing further damage, which was quite plausible. So the experiments were worth doing, but should not have become the whole ball of wax. One of the things which puzzled me was the absolute lack of interest in our AD colleagues over the role of the intramolecular large fragment of the APP. Does it behave differently after the amyloid cleavage has occurred? Does it tie into various cellular signaling pathways, like most transmembrane proteins with a prominent intracellular domain? There are cell surface receptors which are activated by proteolysis. Is APP one of them? Does the APP cleavage, or something else tie in with the obviously damaging, like punch holes through cell membranes, phosphorylation of Tau, and formation of paired helical filaments? There just seemed to be a lack of curiosity about other explanations.
My dissertation involved some crystallographic work in this field (not amyloid fibrils). I want to add from my experience (from my brief time in the field) there seems to be a real lack of understanding as to what APP really does, and even less of an understanding as to what the closely related family members APLP1 and APLP2 do. This is remarkable considering how this protein has been studied heavily since the 90s. From a biological standpoint I don't find the previous associations with copper transport at all convincing and definitely not held up by modern studies.

It's obvious that the APP family members have extremely important roles in neurodevelopment (many, good in vitro and in vivo studies here), but I'm confused from my current interactions with people still involved in the field how little effort is made to understand what these proteins actually do.
 
Upvote
28 (28 / 0)
As someone who has this terrible disease run in their family and whose mom was just moved up from mild to moderate dementia, I really hope we find something. I just feel that this being such a complex disease, we won’t find anything to markedly slow it down. However I did on here not too long ago that people who took the Shingrix vaccine did have lower chances of developing this. The studies were early, but still relatively promising.
 
Upvote
18 (18 / 0)
Scientists weren’t really sure what amyloid-β did, but another study found plenty of it in the brains of people with Down syndrome, who often suffer from dementia later in life.
I found this quoted bit above quite interesting, could it be that Alzheimer's is associated with people who carry part of the genetic defect needed to cause down syndrome in their DNA, but not all of it?
 
Upvote
2 (4 / -2)